Monday to Saturday
10 AM to 5 PM

+91-9935816965,
+91-8979814814

Khasra No.231/1 Arcadia Grant, Mohanpur, Prem Nagar,
Dehradun-248007, UK (INDIA).

Consultancy Services

  • NABL Accreditation
  • GMP Certification
  • BIS Certification
  • DSIR Recognition

NABL Accreditation

An NABL accredited laboratory sounds reliable to the customers. QBRL is the prime source that can get your laboratory accredited by the NABL. QBRL offer consultancy that will help you to upgrade you laboratories as per the National Accreditation Board for Testing and Calibration Laboratories guidelines. The accreditation will help to provide the confidence to the customers in accepting testing reports.

Benefits of Accreditation

Formal recognition of a laboratory by an Accreditation body in compliance with international standards has many benefits:

  • Potential increase in business due to higher customer's confidence and satisfaction
  • Increase of confidence in Testing / Calibration data Excellent feedback to laboratories due to their technical competence as they have sound Quality Assurance System
  • Better control of laboratory operations
  • Saves time and money as it eliminates the requirements for re-testing of products
  • High confidence on personnel performing work
  • Customers can find and identify the laboratories accredited by NABL much easily and for their specific requirements from the Directory of Accredited Laboratories
  • Users of accredited laboratories can entertain greater access for their products, in both national and international markets, as tested by accredited laboratories

GMP Certification

Good manufacturing practice is part and parcel of quality system that encompasses manufacturing and testing of active food ingredients, pharmaceutical ingredients and products, diagnostics, and medical devices. QBRL offer consultancy on attaining GMP Certification that will give your product a high boost in the market. W.H.O. defines Good Manufacturing Practices (GMP) as "that part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the marketing authorization". GMP covers all aspects of the manufacturing process: defined manufacturing process; validated critical manufacturing steps; suitable premises, storage, transport; qualified and trained production and quality control personnel; adequate laboratory facilities; approved written procedures and instructions; records to show all steps of defined procedures taken; full traceability of a product through batch processing records and distribution records; and systems for recall and investigation of complaints.

BIS Certification

Bureau of Indian Standards Act, 1986", that will give your product a high boost in the market. Presence of ISI certification mark known as Standard Mark on a product is an assurance of conformity to the specifications. The conformity is ensured by regular surveillance of the licensee's performance by surprise inspections and testing of samples, drawn both from the market and factory. QBRL provide complete consultancy that will help you to upgrade you laboratories as per the BIS Standard guidelines. The Certification will provide platform to take business from national and international agencies.

DSIR Recognition

The Department of Scientific & Industrial Research (DSIR) is operating a scheme for granting recognition & registration to in-house R&D units established by corporate industry. QBRL is the prime source that can get your R & D Laboratories Recognition with DSIR, Government of India. QBRL provide complete consultancy that will help you to upgrade you R&D laboratories as per the National Standard of Department of Science and Technology guidelines. The Recognition will provide platform to take findings from national and international agencies.

CRITERIA FOR RECOGNITION

  • ­The company must spell out a long term R&D policy which should be displayed prominently in the in-house R&D unit.
  • R&D activities should be separate from routine activities of the firm, such as, production and quality control. The units should have separate & identifiable infrastructure for carrying out R&D work.
  • It is preferable that the in-house R&D unit be located outside the factory premises, or it may be located in a separate building within the factory premises or it may be located in a separate floor. In case of small companies, the R&D unit may be located in a separate room or area. The R&D activities should be clearly demarcated from the manufacturing/ quality control activities.
  • The R&D units should have well defined, time bound R&D programmes. The unit should maintain proper record of its R&D activities in the form of documentation.
  • The units should have qualified staff exclusively engaged in R&D and should be headed by a full-time qualified & experienced R&D person who has direct access to the Chief Executive or to the Board of Directors, depending on the size of the company. The number of R&D manpower should be commensurate with the S&T manpower size of the company.
  • The R&D units should maintain separate books of accounts for all the R&D expenditures. Expenditure should be booked when incurred and not allocated. The company should reflect the R&D expenditure (both capital & revenue) in the Annual Report and Statement of Accounts of the company in separate schedules. The R&D expenditure incurred should be commensurate with the financial size of the company.

FISCAL INCENTIVES AND SUPPORT MEASURES

There are number of fiscal incentives and other support measures aimed at promoting R&D in industry and also at encouraging the utilization of locally available R&D options for industrial development. Some of them are as follows:

Incentives based on direct taxes (Income-tax Act, 1961)

  • 100% write off of revenue expenditure on R&D; (Section 35(1)(i) of IT Act).

  • 100% write off of capital expenditure on R&D in the year the expenditure is incurred; (Section 35(1)(iv) of IT Act).

  • Weighted tax deduction @175% (to the sponsor) for payments made to approved national laboratories, universities and IITs or a specified person, with a specific direction that the said sum shall be used for scientific research under a programme. (Section 35(2AA) of the IT Act).

  • Weighted tax deduction @200% on expenditure (other than land & buildings) incurred on approved in-house R&D facilities of companies engaged in the business of bio-technology or in any business of manufacture or production of any article or thing, not being an article or thing specified in the list of the Eleventh Schedule. [Expenditure on scientific research in relation to drugs and pharmaceuticals, includes expenditure incurred on clinical drug trials, obtaining approvals from any regulatory authority under any Central, State or Provincial Act and filing an application for a patent under the Patents Act, 1970 (39 of 1970). (Section 35(2AB) of the IT Act.)

  • Accelerated depreciation allowance for investment on plant and machinery, made on the basis of indigenous technology (Rule 5(2) of IT Rules, 1962).

Incentives based on indirect taxes

  • Customs duty exemption to in-house R&D units established by corporate companies, other than a Hospital for capital equipment and consumables needed for R&D. (Notification No.24/2007-customs, dated 01 March, 2007 as amended from time to time).

  • Central excise duty exemption to in-house R&D units established by corporate companies, other than a Hospital for capital equipment and consumables needed for R&D.. (Notification No.16/2007-central excise, dated 01 March, 2007 as amended from time to time).

  • Central excise duty waiver for 3 years on goods designed and developed by a wholly owned Indian company and patented in any two countries out of: India, USA, Japan and any one country of European Union (Notification No.15/96-CE dated July 23, 1996, amended vide Notification No.13/99-CE dated 28 February, 1999).

  • Exemption from customs duty on imports made for R&D projects funded by Government in industry. (Notification No.50/96-Customs dated 23 July 1996).

  • Goods specified in List-28 (comprising of analytical and specialty equipment) for use in pharmaceutical and biotechnology sector allowed to be imported duty free {notification No. 26/2003-Customs dated 1 March 2003 (entry substituted at S. No. 248 of the table in the said notification)} Subject to conditions mentioned in the notifications.